Regulation of Colonic Mucosal MicroRNA Expression via Multiple Targets in Visceral Hypersensitivity Rats by Tongxieyaofang

키워드

참고문헌 (38)

1. Longstreth GF, "Functional bowel disorders", Gastroenterology, 130, pp.1480~1491 (2006)[DOI]
2. Verne GN, "Hypersensitivity to visceral and cutaneous pain in the irritable bowel syndrome", Pain, 93, pp.7~14 (2001)[DOI]
3. Zhou Q, "Intestinal membrane permeability and hypersensitivity in the irritable bowel syndrome", Pain, 146, pp.41~46 (2009)[DOI]
4. Camilleri M, "Understanding measurements of intestinal permeability in healthy humans with urine lactulose and mannitol excretion", Neurogastroenterol Motil, 22, pp.e15~e26 (2010)
5. Zhou Q, "New insights into visceral hypersensitivity--clinical implications in IBS", Nat Rev Gastroenterol Hepatol, 8, pp.349~355 (2011)[DOI]
6. Zhou Q, "Decreased miR-199 augments visceral pain in patients with IBS through translational upregulation of TRPV1", Gut, 65, pp.797~805 (2016)[DOI]
7. Kim J, "Identification of many microRNAs that copurify with polyribosomes in mammalian neurons", Proc Natl Acad Sci U S A, 101, pp.360~365 (2004)[DOI]
8. Garzon R, "Targeting microRNAs in cancer: rationale, strategies and challenges", Nat Rev Drug Discov, 9, pp.775~789 (2010)[DOI]
9. Zhou Q, "MicroRNA-29a regulates intestinal membrane permeability in patients with irritable bowel syndrome", Gut, 59, pp.775~784 (2010)[DOI]
10. Liao XJ, "MicroRNA-24 inhibits serotonin reuptake transporter expression and aggravates irritable bowel syndrome", Biochem Biophys Res Commun, 469, pp.288~293 (2016)[DOI]
11. Fourie NH, "Elevated circulating miR-150 and miR-342-3p in patients with irritable bowel syndrome", Exp Mol Pathol, 96, pp.422~425 (2014)[DOI]
12. Yang QQ, "Differential expression of microRNA related to irritable bowel syndrome in a rabbit model", J Dig Dis, 18, pp.330~342 (2017)[DOI]
13. Johnston DGW, "Loss of microRNA-21 influences the gut microbiota, causing reduced susceptibility in a murine model of colitis", J Crohns Colitis, 12, pp.835~848 (2018)[DOI]
14. Ma G, "Upregulation of microRNA-23a", b promotes tumor progression and confers poor prognosis in patients with gastric cancer, 2014, pp.7, 8833~8840
15. Xu X, "MiR-122-5p inhibits cell migration and invasion in gastric cancer by down-regulating DUSP4", Cancer Biol Ther, 19, pp.427~435 (2018)[DOI]
16. Lin XT, "MicroRNA-143 targets ATG2B to inhibit autophagy and increase inflammatory responses in Crohn's disease", Inflamm Bowel Dis, 24, pp.781~791 (2018)[DOI]
17. Kim H, "Pomegranate polyphenolics reduce inflammation and ulceration in intestinal colitis-involvement of the <TEX>$miR-145", p70S6K1, TEX> axis in vivo and in vitro, pp.J Nutr Biochem, 2017[DOI]
18. Szucs D, "Increased duodenal expression of miR-146a and -155 in pediatric Crohn's disease", World J Gastroenterol, 22, pp.6027~6035 (2016)[DOI]
19. Shen Y, "miR-200b inhibits <TEX>$TNF-{\alpha}-induced$<", TEX> IL-8 secretion and tight junction disruption of intestinal epithelial cells in vitro, 2017, pp.312, G123~G132
20. Heckmann D, "The disparate twins: a comparative study of CXCR4 and CXCR7 in <TEX>$SDF-1{\alpha}-induced$<", TEX> gene expression, invasion and chemosensitivity of colon cancer, 2014, pp.20, 604~616
21. Peck BC, "Functional transcriptomics in diverse intestinal epithelial cell types reveals robust MicroRNA sensitivity in intestinal stem cells to microbial status", J Biol Chem, 292, pp.2586~2600 (2017)[DOI]
22. Olaru AV, "Dynamic changes in the expression of MicroRNA-31 during inflammatory bowel disease-associated neoplastic transformation", Inflamm Bowel Dis, 17, pp.221~231 (2011)[DOI]
23. Drossman DA, "The functional gastrointestinal disorders and the Rome III process", Gastroenterology, 130, pp.1377~1390 (2006)[DOI]
24. Thompson WG, "Irritable bowel syndrome in general practice: prevalence, characteristics, and referral", Gut, 46, pp.78~82 (2000)[DOI]
25. Full-Young Chang, "The Current Prevalence of Irritable Bowel Syndrome in Asia", Journal of Neurogastroenterology and Motility (JNM), 16(4), pp.389~400 (2010), 대한소화기 기능성질환∙운동학회
26. Corsetti M, "The quest for biomarkers in IBS-where should it lead us?", Neurogastroenterol Motil, 26, pp.1669~1676 (2014)[DOI]
27. Farh KK, "The widespread impact of mammalian MicroRNAs on mRNA repression and evolution", Science, 310, pp.1817~1821 (2005)[DOI]
28. Sima X, "A potential polymorphism in the promoter of let-7 is associated with an increased risk of intracranial aneurysm: a case-control study", Medicine (Baltimore), 94, pp.e2267~ (2015)[DOI]
29. Sun Y, "MicroRNA let-7i regulates dendritic cells maturation targeting interleukin-10 via the Janus kinase 1-signal transducer and activator of transcription 3 signal pathway subsequently induces prolonged cardiac allograft survival in rats", J Heart Lung Transplant, 35, pp.378~388 (2016)[DOI]
30. Davoodian N, "Let-7f microRNA negatively regulates hepatic differentiation of human adipose tissue-derived stem cells", J Physiol Biochem, 70, pp.781~789 (2014)[DOI]
31. Li M, "Role of dendritic cell-mediated abnormal immune response in visceral hypersensitivity", Int J Clin Exp Med, 8, pp.13243~13250 (2015)
32. Rieger JK, "Inflammation-associated microRNA-130b down-regulates cytochrome P450 activities and directly targets CYP2C9", Drug Metab Dispos, 43, pp.884~888 (2015)[DOI]
33. Salta E, "A self-organizing miR-132", Ctbp2 circuit regulates bimodal notch signals and glial progenitor fate choice during spinal cord maturation, 2014, pp.30, 423~436
34. Chen WX, "Implication of miRNAs for inflammatory bowel disease treatment: systematic review", World J Gastrointest Pathophysiol, 5, pp.63~70 (2014)[DOI]
35. Mussnich P, "MiR-199a-5p and miR-375 affect colon cancer cell sensitivity to cetuximab by targeting PHLPP1", Expert Opin Ther Targets, 19, pp.1017~1026 (2015)[DOI]
36. Bian Z, "Effectiveness of the Chinese herbal formula TongXieYaoFang for irritable bowel syndrome: a systematic review", J Altern Complement Med, 12, pp.401~407 (2006)[DOI]
37. Liao H, "Elucidation of danzhixiaoyao wan and its constituent herbs on antioxidant activity and inhibition of nitric oxide production", Evid Based Complement Alternat Med, 4, pp.425~430 (2007)[DOI]
38. Hu XG, "The alleviating pain effect of aqueous extract from tong-xie-yao-fang, on experimental visceral hypersensitivity and its mechanism", Biol Pharm Bull, 32, pp.1075~1079 (2009)[DOI]

관련 논문AI추천